Kimpe Marc
SVP, Research & Development at ADTN
- Sold, on record
- $100k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Feb 24, 2022
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- ADTNADTRAN INCSVP, Research & Development
Sales by reason
0
Routine
1
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Feb 24, 2022Plan not stated
Sold 15.4% of their holdings
$100k5,000 shares at $20.02
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Jul 8, 2022 | ADTN | SVP, Research & Development | Returned to the companyIncentive Stock Option (Right to Buy) | 30,600 | 0 | SEC | ||
| Jul 8, 2022 | Jul 8, 2022 | ADTN | SVP, Research & Development | Returned to the company | 27,527 | 0 | SEC | ||
| Jun 2, 2022 | Jun 3, 2022 | ADTN | SVP, Research & Development | Awarded | 42 | $18.69 | $794 | 27,527 | SEC |
| Mar 3, 2022 | Mar 7, 2022 | ADTN | SVP, Research & Development | Awarded | 39 | $20.48 | $791 | 27,484 | SEC |
| Feb 24, 2022 | Mar 1, 2022 | ADTN | SVP, Research & Development | Sold | 5,000 | $20.02 | $100k | 27,446 | SEC |
| Feb 24, 2022 | Mar 1, 2022 | ADTN | SVP, Research & Development | Exercised options | 5,000 | $16.97 | $85k | 32,446 | SEC |
| Nov 30, 2021 | Dec 2, 2021 | ADTN | SVP, Research & Development | Awarded | 24 | $20.83 | $507 | 27,446 | SEC |
| Nov 17, 2021 | Nov 19, 2021 | ADTN | SVP, Research & Development | Awarded | 4,216 | 27,421 | SEC | ||
| Nov 16, 2021 | Nov 17, 2021 | ADTN | SVP, Research & Development | Withheld for tax | 1,009 | $21.52 | $22k | 23,205 | SEC |
| Nov 11, 2021 | Nov 15, 2021 | ADTN | SVP, Research & Development | Withheld for tax | 214 | $20.77 | $4k | 24,214 | SEC |
| Nov 9, 2021 | Nov 12, 2021 | ADTN | SVP, Research & Development | Withheld for tax | 335 | $20.91 | $7k | 24,428 | SEC |
| Sep 2, 2021 | Sep 7, 2021 | ADTN | SVP, Research & Development | Awarded | 49 | $17.29 | $844 | 24,763 | SEC |
| Jun 3, 2021 | Jun 7, 2021 | ADTN | SVP, Research & Development | Awarded | 18 | $20.04 | $351 | 24,715 | SEC |
| Nov 16, 2020 | Nov 18, 2020 | ADTN | SVP, Research & Development | Awarded | 7,153 | 24,697 | SEC | ||
| Nov 15, 2020 | Nov 16, 2020 | ADTN | SVP, Research & Development | Withheld for tax | 950 | $12.58 | $12k | 17,544 | SEC |
| Nov 11, 2020 | Nov 12, 2020 | ADTN | SVP, Research & Development | Withheld for tax | 661 | $12.06 | $8k | 18,494 | SEC |
| Nov 25, 2019 | Nov 25, 2019 | ADTN | SVP, Research & Development | Bought | 3,000 | $9.02 | $27k | 19,155 | SEC |
| Nov 15, 2019 | Nov 19, 2019 | ADTN | SVP, Research & Development | Awarded | 9,405 | 19,280 | SEC | ||
| Nov 12, 2019 | Nov 20, 2019 | ADTN | SVP, Research & Development | Returned to the company | 3,125 | $9.66 | $30k | 16,155 | SEC |